Ventodep ER 150 mg Cranialz

£36.00

Ventodep ER 150 mg Cranialz is an extended-release venlafaxine hydrochloride formulation designed for controlled laboratory release studies. This research-grade pharmaceutical preparation allows investigators to examine sustained-release kinetics in analytical environments.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ventodep ER 150 mg Cranialz
Ventodep ER 150 mg Cranialz
£36.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Product Overview: Ventodep ER

Ventodep ER 150 mg Cranialz is an extended-release formulation of venlafaxine hydrochloride, a serotonin-norepinephrine reuptake inhibitor (SNRI) compound. This pharmaceutical-grade preparation features controlled-release technology that enables researchers to investigate drug release kinetics, pharmacokinetic profiles, and sustained-release mechanisms in laboratory settings. The compound belongs to the phenylethylamine class and offers valuable research applications for pharmaceutical scientists studying antidepressant mechanisms and extended-release formulation technologies.

Researchers at Stroid UK Shop can examine this compound’s unique dual-action profile on monoamine transporters. The extended-release matrix allows for controlled dissolution studies and bioavailability research. Investigators studying venlafaxine preparations can analyse the compound’s release characteristics using various analytical methods including HPLC and dissolution testing protocols.

Research Applications

Laboratory studies examine Ventodep ER’s controlled-release properties and sustained-action mechanisms in analytical environments. Pharmaceutical researchers investigate the compound’s dissolution kinetics, matrix integrity, and release modulation under various pH conditions. The extended-release formulation provides opportunities to study drug delivery technologies and sustained pharmacological activity profiles.

Research teams analyse the compound’s stability under accelerated storage conditions and evaluate release consistency across different environmental parameters. Studies encompass dissolution medium compatibility, release rate variability, and formulation robustness testing. Comparative analyses with other selective receptor modulators and bioactive peptides enhance understanding of sustained-release pharmaceutical technologies.

Technical Specifications

Ventodep ER 150 mg Analytical Properties
Parameter Specification
Compound Name Venlafaxine Hydrochloride ER
Dosage Strength 150 mg
Formulation Type Extended Release
Manufacturer Cranialz
CAS Number Verify with supplier
Molecular Formula Verify with supplier
Storage Requirements Room temperature, dry conditions

Compliance and Usage

This product is manufactured for in-vitro research purposes exclusively and is not intended for human consumption, clinical application, or therapeutic use. Researchers must maintain appropriate laboratory safety protocols and analytical documentation when investigating this compound’s properties and characteristics in controlled research environments.

Related